SEC Comment Letter 0000000000-23-001931 to Legend Biotech Corp (LEGN) (CIK 0001801198) (LEGN)
Legend Biotech Corp (LEGN) (CIK 0001801198)
Date: Feb. 27, 2023 · CIK: 0001801198 · Accession: 0000000000-23-001931
AI Filing Summary & Sentiment
File numbers found in text: 001-39307
Letter
United States securities and exchange commission logo February 27, 2023 Ying Huang, Ph.D. Chief Executive Officer Legend Biotech Corporation 2101 Cottontail Lane Somerset, NJ 08873 Re:Legend Biotech Corp Form 20-F for Fiscal Year Ended December 31, 2021 File No. 001-39307 Dear Ying Huang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mark Ballantyne
Show Raw Text
United States securities and exchange commission logo
February 27, 2023
Ying Huang, Ph.D.
Chief Executive Officer
Legend Biotech Corporation
2101 Cottontail Lane
Somerset, NJ 08873
Re:Legend Biotech Corp
Form 20-F for Fiscal Year Ended December 31, 2021
File No. 001-39307
Dear Ying Huang:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mark Ballantyne